These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25188417)

  • 21. Therapeutic hemoglobin levels after gene transfer in β-thalassemia mice and in hematopoietic cells of β-thalassemia and sickle cells disease patients.
    Breda L; Casu C; Gardenghi S; Bianchi N; Cartegni L; Narla M; Yazdanbakhsh K; Musso M; Manwani D; Little J; Gardner LB; Kleinert DA; Prus E; Fibach E; Grady RW; Giardina PJ; Gambari R; Rivella S
    PLoS One; 2012; 7(3):e32345. PubMed ID: 22479321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Globin sleeping beauty transposon reduces red blood cell sickling in a patient-derived CD34(+)-based in vitro model.
    Sjeklocha LM; Wong PY; Belcher JD; Vercellotti GM; Steer CJ
    PLoS One; 2013; 8(11):e80403. PubMed ID: 24260386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidative stress status, clinical outcome, and β-globin gene cluster haplotypes in pediatric patients with sickle cell disease.
    Rusanova I; Escames G; Cossio G; de Borace RG; Moreno B; Chahboune M; López LC; Díez T; Acuña-Castroviejo D
    Eur J Haematol; 2010 Dec; 85(6):529-37. PubMed ID: 20846340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sickling of nucleated erythroid precursors from patients with sickle cell anemia.
    Hasegawa S; Rodgers GP; Dwyer N; Noguchi CT; Blanchette-Mackie EJ; Uyesaka N; Schechter AN; Fibach E
    Exp Hematol; 1998 Apr; 26(4):314-9. PubMed ID: 9546314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
    Bauer DE; Orkin SH
    Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
    [TBL] [Abstract][Full Text] [Related]  

  • 26. β-globin gene cluster haplotypes in sickle cell patients from Panamá.
    Rusanova I; Cossio G; Moreno B; Javier Perea F; De Borace RG; Perea M; Escames G; Acuña-Castroviejo D
    Am J Hum Biol; 2011; 23(3):377-80. PubMed ID: 21387457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ineffective erythropoiesis in sickle cell disease: new insights and future implications.
    El Nemer W; Godard A; El Hoss S
    Curr Opin Hematol; 2021 May; 28(3):171-176. PubMed ID: 33631786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MIR-144-mediated NRF2 gene silencing inhibits fetal hemoglobin expression in sickle cell disease.
    Li B; Zhu X; Ward CM; Starlard-Davenport A; Takezaki M; Berry A; Ward A; Wilder C; Neunert C; Kutlar A; Pace BS
    Exp Hematol; 2019 Feb; 70():85-96.e5. PubMed ID: 30412705
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease.
    Lettre G; Sankaran VG; Bezerra MA; Araújo AS; Uda M; Sanna S; Cao A; Schlessinger D; Costa FF; Hirschhorn JN; Orkin SH
    Proc Natl Acad Sci U S A; 2008 Aug; 105(33):11869-74. PubMed ID: 18667698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lentiviral and genome-editing strategies for the treatment of β-hemoglobinopathies.
    Magrin E; Miccio A; Cavazzana M
    Blood; 2019 Oct; 134(15):1203-1213. PubMed ID: 31467062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease.
    Sun Y; Benmhammed H; Al Abdullatif S; Habara A; Fu E; Brady J; Williams C; Ilinski A; Sharma A; Mahdaviani K; Alekseyev YO; Campbell JD; Steinberg MH; Cui S
    Sci Adv; 2024 Aug; 10(31):eadn8750. PubMed ID: 39083598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.
    Ikuta T; Adekile AD; Gutsaeva DR; Parkerson JB; Yerigenahally SD; Clair B; Kutlar A; Odo N; Head CA
    Blood Cells Mol Dis; 2011 Dec; 47(4):235-42. PubMed ID: 21945571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the β(A(T87Q))-Globin Gene.
    Negre O; Eggimann AV; Beuzard Y; Ribeil JA; Bourget P; Borwornpinyo S; Hongeng S; Hacein-Bey S; Cavazzana M; Leboulch P; Payen E
    Hum Gene Ther; 2016 Feb; 27(2):148-65. PubMed ID: 26886832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.
    Shearstone JR; Golonzhka O; Chonkar A; Tamang D; van Duzer JH; Jones SS; Jarpe MB
    PLoS One; 2016; 11(4):e0153767. PubMed ID: 27073918
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Role of miRNAs as Therapeutic Tools in Sickle Cell Disease.
    Cyrus C
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684143
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel human gamma-globin gene vector for genetic correction of sickle cell anemia in a humanized sickle mouse model: critical determinants for successful correction.
    Perumbeti A; Higashimoto T; Urbinati F; Franco R; Meiselman HJ; Witte D; Malik P
    Blood; 2009 Aug; 114(6):1174-85. PubMed ID: 19474450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hereditary persistence of hemoglobin F is protective against red cell sickling. A case report and brief review.
    Sokolova A; Mararenko A; Rozin A; Podrumar A; Gotlieb V
    Hematol Oncol Stem Cell Ther; 2019 Dec; 12(4):215-219. PubMed ID: 29079125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease.
    Menzel S; Thein SL
    Mol Diagn Ther; 2019 Apr; 23(2):235-244. PubMed ID: 30478714
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A mass spectrometry assay for detection of endogenous and lentiviral engineered hemoglobin in cultured cells and sickle cell disease mice.
    Wang X; McKillop WM; Dlugi TA; Faber ML; Alvarez-Argote J; Chambers CB; Wilber A; Medin JA
    J Gene Med; 2024 Jan; 26(1):e3567. PubMed ID: 37455676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.